Supplementary MaterialsSupplementary information 41598_2018_33852_MOESM1_ESM. conclusion, whilst oncogenic KRAS mutation might activate
Supplementary MaterialsSupplementary information 41598_2018_33852_MOESM1_ESM. conclusion, whilst oncogenic KRAS mutation might activate Yap in other cell types, we could find no evidence for this in myoblasts because the expression of expression did not change Yap/Taz activity in myoblasts and there was a limited overlap in gene expression between and fusion genes, and embryonal rhabdomyosarcoma (ERMS), which … [Read more…]